rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2010-735rsp-872Research ArticleСтатьиArticlesНАРУШЕНИЯ СНА У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ И СИСТЕМНОЙ КРАСНОЙ ВОЛЧАНКОЙ: ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ПРЕПАРАТА ЗОЛПИДЕМ (САНВАЛ)NARUShENIYa SNA U BOL'NYKh REVMATOIDNYM ARTRITOM I SISTEMNOY KRASNOY VOLChANKOY: EFFEKTIVNOST' I BEZOPASNOST' PREPARATA ZOLPIDEM (SANVAL)ЛисицынаТ. А.LisitsynaTatyana Andreyevnatalisitsyna@rambler.ruSeravinaO FSeravinaO F-Vel'tishchevD YuVel'tishchevD Yu-201015102010485№5 (2010)8084Copyright © Лисицына Т.А., Seravina O.F., Vel'tishchev D.Y., 20102010Лисицына Т.А., Seravina O.F., Vel'tishchev D.Y.Lisitsyna T.A., Seravina O.F., Vel'tishchev D.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/872References<div><p>Abad V.C., Sarinas P., Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 2008; 12: 211-28.</p><p>Wolfe F., Michaud K., Li T. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scale. J Rheumatol 2006; 33: 1942-51.</p><p>Treharne G.J., Lyons A.C., Hale E.D. et al. Sleep disruption frequency in rheumatoid arthritis: perceived stress predicts poor outcome over one year. Musculoskeletal Care 2007; 5(1): 51-64.</p><p>Leigh T.J., Bird H.A., Hindmarch I. A comparison of sleep in rheumatic and non-rheumatic patients. Clin Exp Rheumatol 1987; 5: 363-5.</p><p>Irwin M.R., Davis M., Zautra A. Behavioral comorbidities in rheumatoid arthritis: Psychoneuroimmunological perspective. Psychiatr Times 2008; 25(9): 1.</p><p>Аведисова А.С., Ястребова В.В., Ястребов Д.В. Клиника, диагностика и лечение инсомнических расстройств. Доктор.Ру 2009; 4: 7-15.</p><p>Neubauer D.N. State-of-the-art sleep management. Manag Care 2006; 15(9): 6-12.</p><p>Jasper D. Pharmacotherapy of insomnia: practice and prospects. Pharm World Sci 1995; 17(3): 67-75.</p><p>Nowell P.D., Mazumdar S., Buysse D.J. et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997; 278(24): 2170-217.</p><p>Perlis M.C., McCall M.V., Krystal A.D. Long- term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatr 2004; 65: 1128-37.</p><p>Arnrett F.C., Edworth S.M., Bloch D.A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 1988; 31: 315-24.</p><p>Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1997; 40: 1725.</p><p>Fransen J., Stucki G., van Riel PL.C.M. Rheumatoid arthritis measures. Arthr Care Res 2003; 49: 214-24.</p><p>Bombardier C., Gladman D.D., Urowitz M.B. et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthr Rheum 1992; 35(6): 630-40.</p><p>Daut R., Cleeland C., Flanery R. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17(2): 197-210.</p><p>Pincus T., Swearingen C., Wolf F. Toward a multydimensional Health Assessment Questionnaire (MDHAQ) - assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthr Rheum 1999; 42: 2220-30.</p><p>Rabin R., de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-43.</p><p>Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.</p><p>Левин Я.И., Вейн A.M. Проблема инсомнии в общемедицинской практике. РМЖ 1996; 3: 16-9.</p><p>Moul D.E., Pilkinis P.A. Preliminary study of the test-retest reliability and concurrent validities of the Pittsburg insomnia rating scale. Sleep 2002; 25: 246-7.</p><p>Dundar Y., Boland A., Strobl J. et al. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assessment 2004; 8: 24.</p></div><br /><div><p>Abad V.C., Sarinas P., Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 2008; 12: 211-28.</p><p>Wolfe F., Michaud K., Li T. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scale. J Rheumatol 2006; 33: 1942-51.</p><p>Treharne G.J., Lyons A.C., Hale E.D. et al. Sleep disruption frequency in rheumatoid arthritis: perceived stress predicts poor outcome over one year. Musculoskeletal Care 2007; 5(1): 51-64.</p><p>Leigh T.J., Bird H.A., Hindmarch I. A comparison of sleep in rheumatic and non-rheumatic patients. Clin Exp Rheumatol 1987; 5: 363-5.</p><p>Irwin M.R., Davis M., Zautra A. Behavioral comorbidities in rheumatoid arthritis: Psychoneuroimmunological perspective. Psychiatr Times 2008; 25(9): 1.</p><p>Аведисова А.С., Ястребова В.В., Ястребов Д.В. Клиника, диагностика и лечение инсомнических расстройств. Доктор.Ру 2009; 4: 7-15.</p><p>Neubauer D.N. State-of-the-art sleep management. Manag Care 2006; 15(9): 6-12.</p><p>Jasper D. Pharmacotherapy of insomnia: practice and prospects. Pharm World Sci 1995; 17(3): 67-75.</p><p>Nowell P.D., Mazumdar S., Buysse D.J. et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997; 278(24): 2170-217.</p><p>Perlis M.C., McCall M.V., Krystal A.D. Long- term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatr 2004; 65: 1128-37.</p><p>Arnrett F.C., Edworth S.M., Bloch D.A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 1988; 31: 315-24.</p><p>Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1997; 40: 1725.</p><p>Fransen J., Stucki G., van Riel PL.C.M. Rheumatoid arthritis measures. Arthr Care Res 2003; 49: 214-24.</p><p>Bombardier C., Gladman D.D., Urowitz M.B. et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthr Rheum 1992; 35(6): 630-40.</p><p>Daut R., Cleeland C., Flanery R. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17(2): 197-210.</p><p>Pincus T., Swearingen C., Wolf F. Toward a multydimensional Health Assessment Questionnaire (MDHAQ) - assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthr Rheum 1999; 42: 2220-30.</p><p>Rabin R., de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-43.</p><p>Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.</p><p>Левин Я.И., Вейн A.M. Проблема инсомнии в общемедицинской практике. РМЖ 1996; 3: 16-9.</p><p>Moul D.E., Pilkinis P.A. Preliminary study of the test-retest reliability and concurrent validities of the Pittsburg insomnia rating scale. Sleep 2002; 25: 246-7.</p><p>Dundar Y., Boland A., Strobl J. et al. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assessment 2004; 8: 24.</p></div><br />
The authors declare that there are no conflicts of interest present.